Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rotonya M Carr

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of Lipid Research|October 3, 2019
α-Galactosylceramide: a potent immunomodulator produced by gut microbesRotonya M Carr
Hepatology Communications|September 27, 2023
Embracing the principles of practice transfer to get the word out on the new metabolic dysfunction-associated steatotic liver disease nomenclatureRotonya M Carr
The Journal of Clinical Investigation|September 24, 2020
Reflections of a Black woman physician-scientistRotonya M Carr
Cellular and Molecular Gastroenterology and Hepatology|August 26, 2017
In NAFLD, You Are What You Eat, Not Simply How Much You EatRotonya M Carr
Digestive Diseases and Sciences|July 30, 2022
DDS Profile: Rotonya M. Carr, MD, FACPRotonya M Carr
Hepatology (Baltimore, Md.)|January 31, 2018
Proton pump inhibitors, Enterococcus, and the liver, oh my!Rotonya M Carr
Cellular and Molecular Gastroenterology and Hepatology|July 3, 2020
Nature or Nurture? The Answer Is "Both" in Nonalcoholic SteatohepatitisRotonya M Carr
The Journal of Clinical Investigation|March 15, 2021
VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitisRotonya M Carr
Digestive Diseases and Sciences|July 30, 2022
DDS Perspective: Time to Get Serious About the Global PandemicRotonya M Carr
Annals of the New York Academy of Sciences|May 23, 2015
Insulin resistance in clinical and experimental alcoholic liver diseaseRotonya M Carr, Jason Correnti
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Lipid Research|October 3, 2019
α-Galactosylceramide: a potent immunomodulator produced by gut microbesRotonya M Carr
Hepatology Communications|September 27, 2023
Embracing the principles of practice transfer to get the word out on the new metabolic dysfunction-associated steatotic liver disease nomenclatureRotonya M Carr
The Journal of Clinical Investigation|September 24, 2020
Reflections of a Black woman physician-scientistRotonya M Carr
Cellular and Molecular Gastroenterology and Hepatology|August 26, 2017
In NAFLD, You Are What You Eat, Not Simply How Much You EatRotonya M Carr
Digestive Diseases and Sciences|July 30, 2022
DDS Profile: Rotonya M. Carr, MD, FACPRotonya M Carr
Hepatology (Baltimore, Md.)|January 31, 2018
Proton pump inhibitors, Enterococcus, and the liver, oh my!Rotonya M Carr
Cellular and Molecular Gastroenterology and Hepatology|July 3, 2020
Nature or Nurture? The Answer Is "Both" in Nonalcoholic SteatohepatitisRotonya M Carr
The Journal of Clinical Investigation|March 15, 2021
VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitisRotonya M Carr
Digestive Diseases and Sciences|July 30, 2022
DDS Perspective: Time to Get Serious About the Global PandemicRotonya M Carr
Annals of the New York Academy of Sciences|May 23, 2015
Insulin resistance in clinical and experimental alcoholic liver diseaseRotonya M Carr, Jason Correnti
Pageof 7